Unlocking Opportunities in the Gabapentin Market: 2025-2034 Forecast Report

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Gabapentin Industry Market Size Be by 2025?
In recent times, there's been significant growth in the size of the gabapentin market. It's projected to increase from $2.78 billion in 2024 to $3.01 billion in 2025, sporting a compound annual growth rate (CAGR) of 8.5%. Factors contributing to the growth during the historic period include the escalating cases of epilepsy, increasing incidents of neuropathic pain, greater awareness of neurological disorders, a growing elderly population, and a surge in the use of generic anticonvulsants.

What's the Long-Term Growth Forecast for the Gabapentin Market Size Through 2029?
In the forthcoming years, the gabapentin market is projected to exhibit robust growth, expanding to a worth of $4.12 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. This surge over the predicted period is due to a rising demand for controlling chronic pain, increased approvals of gabapentin drugs, improved access to health facilities in emerging economies, the growing emphasis on individualized treatment, and an escalating burden of neurological disorders. Key trends anticipated during this period include enhancements in drug delivery systems, the inclusion of gabapentin in combination treatments, tech-propelled R&D for neuropathic pain, progress in extended-release drug variations, and advancements in the application of pharmacogenomics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gabapentin-global-market-report

What Are the Key Growth Drivers Fueling the Gabapentin Market Expansion?
The escalation in epilepsy cases is anticipated to fuel the expansion of the gabapentin market in the future. Characterized by recurring seizures originating from erratic electrical activity in the brain, epilepsy is a neurological disorder. The upsurge in elderly populations mainly accounts for the rise in epilepsy cases since the onset of neurological disorders, leading to seizures, is often linked to aging. Gabapentin's functionality in managing epilepsy lies in its ability to soothe unusual nerve activity in the brain and diminish the signals that trigger seizures. It works by focusing on calcium channels to avert potential seizure events. For example, in May 2024, the Centers for Disease Control and Prevention, a government agency in the US, reported that around 2.9 million American adults over 18 years had active epilepsy in 2022-an increase of 1.08% compared to the previous year, 2021. Therefore, the growing prevalence of epilepsy serves as a catalyst for the thriving gabapentin market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24544&type=smp

What Are the Key Trends Driving Gabapentin Market Growth?
In the gabapentin market, leading companies are investing in the creation of advanced formulations like bioequivalent tablets to improve treatment options for neurological disorders and boost therapeutic efficiency. These generic drugs release the same dose of active ingredient into the bloodstream as their branded counterparts, ensuring comparably safe and therapeutic outcomes. For example, Strides Pharma Science Limited, a pharmaceutical firm based in India, unveiled Gabapentin Tablets USP in the strengths of 600 mg and 800 mg in March 2024. The United States Food & Drug Administration (USFDA) had approved this, thus enabling an expansion of the neurology portfolio within the US market. This revamped gabapentin boasts improved bioavailability, exact dosage, and patient-friendly administration, providing consistent therapeutic results, better symptom management, and increased convenience for long-term treatment. The Gabapentin tablets USP, 600 mg, unveil a flexible therapeutic possibility by offering efficient management of various neurological disorders like neuropathic pain and partial seizures through consistent dosages and proven clinical efficiency.

How Is the Gabapentin Market Segmented?
The gabapentin market covered in this report is segmented -

1) By Type: Generic, Branded
2) By Dosage Form: Tablet, Capsule, Oral Solution
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By Application: Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Other Applications

Subsegments:
1) By Generic: Gabapentin Immediate Release (IR), Gabapentin Extended Release (ER), Gabapentin Capsules, Gabapentin Tablets, Gabapentin Oral Solution
2) By Branded: Neurontin, Gralise, Horizant, Other Branded Formulations

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24544&type=smp

Which Companies Are Leading the Charge in Gabapentin Market Innovation?
Major companies operating in the gabapentin market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Apotex Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., Ipca Laboratories Private Limited, Granules India Limited, Medley Pharmaceuticals Limited, Wockhardt Limited, Epic Pharma LLC, Healing Pharma India Pvt. Ltd., Rochem International Inc., Accord Healthcare Limited, Strides Pharma Science Limited, Ascend Laboratories LLC

Which Regions Are Leading the Global Gabapentin Market in Revenue?
North America was the largest region in the gabapentin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gabapentin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24544

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.